April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Susceptibility Modifiers Contribute to Phenotype Variability in Mouse Arrestin1 Knockout Cone Dystrophy
Author Affiliations & Notes
  • Rosanne M. Yetemian
    Ophthalmology,
    Doheny Eye Institute & Keck School of Medicine, University of Southern California, Los Angeles, California
  • Shun-Ping Huang
    Ophthalmology,
    Doheny Eye Institute & Keck School of Medicine, University of Southern California, Los Angeles, California
  • Bruce M. Brown
    Ophthalmology,
    Doheny Eye Institute & Keck School of Medicine, University of Southern California, Los Angeles, California
  • Guey Shuang Wu
    Ophthalmology,
    Doheny Eye Institute & Keck School of Medicine, University of Southern California, Los Angeles, California
  • Cheryl M. Craft
    Ophthalmology and Cell & Neurobiology,
    Doheny Eye Institute & Keck School of Medicine, University of Southern California, Los Angeles, California
  • Footnotes
    Commercial Relationships  Rosanne M. Yetemian, None; Shun-Ping Huang, None; Bruce M. Brown, None; Guey Shuang Wu, None; Cheryl M. Craft, None
  • Footnotes
    Support  NIH Grant EY015851, NIH EY03040 (DEI), RPB, William Hansen Sandberg Memorial Foundation, Dorie Miller, Tony Gray Found., Mary D. Allen Endowment
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 78. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rosanne M. Yetemian, Shun-Ping Huang, Bruce M. Brown, Guey Shuang Wu, Cheryl M. Craft; Susceptibility Modifiers Contribute to Phenotype Variability in Mouse Arrestin1 Knockout Cone Dystrophy. Invest. Ophthalmol. Vis. Sci. 2011;52(14):78.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Our study focuses on identifying susceptibility modulators involved in the variable Arrestin1 (Arr1)-/- cone dystrophy phenotype. Arr1 contributes to photoreceptor recovery & light adaptation by binding to phosphorylated opsins & interacting with N-ethylmaleimide sensitive factor (NSF). In humans, ARR1 genetic defects lead to Oguchi Disease; in mice, Arr1-/-A have light-dependent retinal degeneration (Chen et al. 1999 IOVS 40:2978) and light-independent cone dystrophy (Arr1-/-B)(Brown et al. 2010 IOVS 51:2372). Light-independent photoreceptor cell death was significanly lower at postnatal day (P)60 in the Arr1-/-A compared to Arr1-/-B.

Methods: : Differential retinal proteomic and genomic expression patterns were examined between founder colony, Arr1-/-A (J. Chen, USC), and Arr1-/-B with EttanTM DIGE, mass spectroscopy (MS), IEF-immunoblot, & allelic specific PCR (ASPCR) analysis. Deregulated retinal transcripts identified with Affymetrix exon array were analyzed using Ingenuity Pathway Analysis (IPA), then verified with quantitative RT-PCR, immunoblot, & immunohistochemistry analysis at P30 & P60.

Results: : Two Peroxiredoxin 6 (Prdx6) proteomic isoforms (pH 6.12 & 5.7), a thiol-specific antioxidant enzyme with PLA2 activity known to differentially regulate reactive oxygen species, were identified by MS, then Prdx6 genomic ASPCR and retinal transcripts verified a SNP(A/C) coding an amino acid variant (A122D): Arr1-/-A has 129SvJ acidic Prdx6 (122D), while Arr1-/-B has C57Bl/6J basic (122A) isoform. Arr1-/-B compared to either control or Arr1-/-A retinal transcripts were significantly up-regulated with enhanced protein expression, including 7 Complement components, Annexin1A, Endothelin2, Oncostatin M receptor, STAT3, SOCS3, & GFAP.

Conclusions: : The susceptibility of Arr1-/-B to light-independent cone dystrophy is a multi-step, complex network linked initially to an acute phase response signaling activation of the Complement System, which is also implicated in the pathogenesis of age-related macular degeneration (AMD). This pathway may be epigenetically protecting Arr1-/-A photoreceptors with the expression of the resistant Prdx6 isoform, which is associated with reduced susceptibility for oxidative damage. Our data links other genes working in concert with Prdx6 that may lead to retinal degeneration susceptibility in other eye diseases, which may provide novel therapeutic approaches for treatment.

Keywords: gene modifiers • transgenics/knock-outs • cell survival 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×